Dear all,
Apologies to all non-Roche users out there:
We have recently switched from the GENT2 Roche Modular gentamicin CEDIA application (now withdrawn) to the reformulated RGENT KIMS assay, and have noticed a significant negative bias for results > 6 mg/L on the new kit. I
was wondering if any other users have made the same observations, and if so what they've done about it?
BW
Emma
Emma Tuddenham
Pre-registration Clinical Scientist
Croydon University Hospital
530 London Road
Thornton Heath
Surrey
CR7 7YE
Tel: 0208 401 3548
Fax: 0208 401 3189